Table 2.
Method | All positive* | False positive* | All negative* | False negative* | False-positive rate | False-negative rate | Kappa value | Mean kappa | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All grade 1 NSQIP complications | ||||||||||||
DC Summary | 10 + | 1+ | 5 - | - | 61 - | 4 - | 1- | 1+ | 1/68 (1.4%) | 5/16 (31.3%) | 0.744 | 0.629 |
Chart Review | 10 + | 1+ | 5 + | - | 61 - | 4 - | 1- | 1+ | 6/68 (8.8%) | 5/16 (31.3%) | 0.585 | |
Prospective | 10 + | 1+ | 5 + | + | 61 - | 4 - | 1+ | 1- | 7/68 (10.3%) | 5/16 (31.3%) | 0.558 | |
NSQIP | 10 + | 1- | 5 - | - | 61- | 4 + | 1+ | 1+ | NA | NA | NA | NA |
All grade 2 NSQIP complications | ||||||||||||
DC Summary | 13 + | 8 + | 1+ | 2 - | 48 - | 6 - | 1- | 5 - | 9/59 (15.3%) | 12/25 (48.0%) | 0.381 | 0.485 |
Chart Review | 13 + | 8 + | 1+ | 2 + | 48 - | 6 - | 1- | 5 + | 11/59 (18.6%) | 7/25 (28.0%) | 0.510 | |
Prospective | 13 + | 8 + | 1- | 2 + | 48 - | 6 - | 1+ | 5 + | 10/59 (16.9%) | 6/25 (24.0%) | 0.564 | |
NSQIP | 13 + | 8 - | 1- | 2 - | 48 - | 6 + | 1+ | 5 + | NA | NA | NA | NA |
All grade 3 to 5 NSQIP complications | ||||||||||||
DC Summary | 12 + | 1- | 71 - | NA | 0/72 (0%) | 0/12 (0%) | 1.000 | 0.969 | ||||
Chart Review | 12 + | 1+ | 71 - | NA | 1/72 (1.4%) | 0/12 (0%) | 0.953 | |||||
Prospective | 12 + | 1+ | 71 - | NA | 1/72 (1.4%) | 0/12 (0%) | 0.953 | |||||
NSQIP | 12 + | 1- | 71 - | NA | NA | NA | NA | NA |
Numbers indicate the number of patients with the particular pattern in those categories.